Supplementation with Natto and Red Yeast Rice Alters Gene Expressions in Cholesterol Metabolism Pathways in ApoE Mice with Concurrent Changes in Gut Microbiota
Overview
Authors
Affiliations
We aimed to examine the effect of natto and red yeast rice (NR) supplementation on lipid and lipoprotein profiles, gene expressions of cholesterol metabolism, and the composition of gut microbiota in ApoE mice. Forty-one male ApoE mice aged 7-8 wks old were randomly fed a control diet (CD), CD + NR (oral gavage at 0.3 g/kg BW/day), high-fat and high-cholesterol diet (HFD), or HFD + NR for 12 wks. Fasting blood samples, liver and intestine tissues and fecal samples were collected at week 12. Biochemical parameters, gene expressions in cholesterol metabolism and gut microbiota composition and diversity were measured using standard methods. NR supplementation had no significant effect on lipid and lipoprotein profiles. Compared with the HFD group, HFD + NR resulted in higher mRNA expressions of HMGCR and CYP7A1 (both < 0.05) and ABCA1 ( = 0.0134, = 0.0407), lower mRNA expression of PCSK9 ( = 0.0002), lower fasting glucose concentrations ( = 0.0011), and lower relative abundance of genera and (both < 0.01) and ( = 0.0007). The relative abundance of was inversely correlated with HMGCR and CYP7A1, and the relative abundance of was positively correlated with PCSK9 and inversely correlated with ABCA1 (all < 0.05). These findings suggest that NR supplementation may regulate gene expressions in cholesterol metabolism via changes in the gut microbiota in HFD-fed ApoE mice.
Hyperlipidaemia treatment and gut microbiology.
Zhe L, ChunLi Y Front Microbiol. 2025; 15():1520252.
PMID: 39867495 PMC: 11758981. DOI: 10.3389/fmicb.2024.1520252.
Dong Y, Zhang Q, Xie R, Zhao J, Han Z, Li Y Nutrients. 2025; 17(1.
PMID: 39796594 PMC: 11722796. DOI: 10.3390/nu17010160.
Song C, Yan Q, Ma Y, Li P, Yang Y, Wang Y Drug Des Devel Ther. 2025; 18:6359-6377.
PMID: 39741920 PMC: 11687096. DOI: 10.2147/DDDT.S482965.
Fermented soybean foods and diabetes.
Hashimoto Y, Hamaguchi M, Fukui M J Diabetes Investig. 2023; 14(12):1329-1340.
PMID: 37799064 PMC: 10688128. DOI: 10.1111/jdi.14088.